Medicare Enrolled
Dr. Marcelo Branco, MD
Cardiovascular Disease · Pensacola, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Branco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Branco? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Branco
Dr. Marcelo Branco is a cardiovascular disease in Pensacola, FL, with 20 years in practice. Based on federal Medicare data, Dr. Branco performed 3,713 Medicare services across 2,121 unique beneficiaries.
Between the years covered by Open Payments, Dr. Branco received a total of $10,521 from 46 pharmaceutical and/or device companies across 414 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Branco is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 32% volume in FL$ $10,521 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,713
Medicare services
Top 32% in FL for cardiovascular disease
2,121
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~186 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 589 | $6 | $30 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 416 | $27 | $70 |
| Remote pacemaker/defibrillator monitoring, 90 days | 365 | $16 | $75 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 322 | $19 | $85 |
| Office visit, established patient (30-39 min) | 295 | $71 | $133 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 256 | $20 | $85 |
| Remote pacemaker monitoring, 90 days | 224 | $22 | $100 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 144 | $26 | $120 |
| Electrocardiogram (EKG), 12-lead | 110 | $11 | $65 |
| Hospital follow-up visit, moderate complexity | 108 | $62 | $150 |
| Initial hospital admission, moderate complexity | 95 | $105 | $280 |
| Programming of dual lead pacemaker system | 94 | $28 | $127 |
| Office visit, established patient, complex (40-54 min) | 89 | $104 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 69 | $786 | $2,435 |
| New patient office visit, complex (60-74 min) | 66 | $145 | $261 |
| New patient office visit (45-59 min) | 59 | $109 | $194 |
| Office visit, established patient (20-29 min) | 55 | $49 | $89 |
| Evaluation of implantable heart and blood vessel monitoring system | 44 | $21 | $90 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 34 | $255 | $925 |
| Programming of dual lead implantable defibrillator system | 32 | $46 | $198 |
| Evaluation of cardiac rhythm monitor system | 30 | $15 | $65 |
| Programming of multiple lead implantable defibrillator system | 28 | $54 | $218 |
| Initial hospital admission, high complexity | 26 | $135 | $420 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 24 | $255 | $925 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $7 | $15 |
| Hospital discharge day management, 30 minutes or less | 21 | $65 | $150 |
| Repair of left upper heart chamber with implant with review by radiologist | 19 | $630 | $1,683 |
| Insertion of heart rhythm monitor under skin | 18 | $67 | $195 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $396 | $1,120 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 16 | $58 | $295 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $697 | $1,815 |
| Hospital follow-up visit, high complexity | 13 | $96 | $215 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.4% high complexity
0.4% medium
72.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,521
Total received (2018-2024)
Avg $1,503/year across 7 years
Top 23% in FL for cardiovascular disease
46
Companies
414
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,373 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$148 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,178
2023$1,028
2022$2,744
2021$462
2020$750
2019$1,648
2018$1,710
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,627
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$818
Janssen Pharmaceuticals, Inc
$646
Biosense Webster, Inc.
$574
Novartis Pharmaceuticals Corporation
$535
E.R. Squibb & Sons, L.L.C.
$500
Amgen Inc.
$371
PFIZER INC.
$309
Boston Scientific Corporation
$307
Boehringer Ingelheim Pharmaceuticals, Inc.
$246
Medtronic Vascular, Inc.
$210
AstraZeneca Pharmaceuticals LP
$194
Philips Electronics North America Corporation
$182
Astellas Pharma US Inc
$180
ABIOMED
$167
Gilead Sciences, Inc.
$163
SANOFI-AVENTIS U.S. LLC
$158
CVRx, Inc.
$150
Braemar Manufacturing, LLC
$120
CARDIVA MEDICAL, INC.
$96
Medtronic, Inc.
$89
Acutus Medical, Inc.
$89
Actelion Pharmaceuticals US, Inc.
$88
Baxter Healthcare
$77
Regeneron Healthcare Solutions, Inc.
$73
Kestra Medical Technology Services, Inc.
$64
Cook Medical LLC
$57
AtriCure, Inc.
$50
ACIST MEDICAL SYSTEMS, INC.
$42
Osprey Medical Inc
$34
Amarin Pharma Inc.
$31
iRhythm Technologies, Inc.
$30
CeloNova BioSciences, Inc.
$24
Lundbeck LLC
$23
PORTOLA PHARMACEUTICALS, INC.
$22
Merck Sharp & Dohme Corporation
$20
CSL Behring
$19
United Therapeutics Corporation
$18
Impulse Dynamics (USA) Inc.
$18
PORTOLA PHARMACEUTICALS, LLC
$17
ARBOR PHARMACEUTICALS, INC.
$16
LifeWatch Services Inc
$16
Aziyo Biologics, Inc.
$16
Merck Sharp & Dohme LLC
$14
Cardiovascular Systems Inc.
$13
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 48.4% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (9278) Bridge · AMPLATZER AMULET · ANDEXXA · ASSURITY · ATRICURE SYNERGY ABLATION SYSTEM · AVEIR · Advisor Catheter · Allure Quadra RF CRT Pacemaker · Assure WCD · BRILINTA · Barostim Neo System · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CRT-Ds · Cardiac Monitoring Suite · CardioMEMS HF System · Carto 3 · Claria MRI · Confirm Rx · Corlanor · DyeVert · ECM Patch · ELIQUIS · ENSITE PRECISION · ENTRESTO · EVOLUTION · Edarbyclor · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · Epi-Sense Guided Coagulation System with VisiTrax · FARXIGA · GlideLight · Hillrom - Carnation Ambulatory Monitor · Impella · JARDIANCE · JOT DX · Kcentra · LEXISCAN · LifeVest · Livalo · MULTAQ · Micra · Models · NORTHERA · OPSUMIT · OPTIMIZER · ORENITRAM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROTONIX · Peripheral Orbital Atherectomy System · Pouch · QDOT MICRO Catheter · QUADRA ASSURA · Quadra Assura CRT Defibrillator · RXI CONSUMABLES · Repatha · Reveal LINQ · TACTICATH · UPTRAVI · VERQUVO · Vascepa · Vascular Closure Device · Viva · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $283 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
37
Per 100K population
11.4
County median income
$65,715
Nearest hospital
HCA FLORIDA WEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Branco is a remote & electrophysiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Branco experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Branco performed 589 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Branco receive payments from pharmaceutical companies?
Yes. Dr. Branco received a total of $10,521 from 46 companies across 414 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Branco's costs compare to other cardiovascular diseases in Pensacola?
Dr. Branco's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Branco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Pensacola
Browse cardiovascular diseases in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology